Even when they do, the repaired tissue is often biomechanically inferior, with a high scar component
A study by Peterson et al (2018) showed that while non-azotaemic cats with elevated pre-treatment SDMA were more likely to develop renal complications following stabilisation of their thyroid disease, unfortunately, having a normal pre-treatment SDMA was no guarantee of protection from renal complications
While no significant changes were detected in the intensity of the liver protein bands, differences in the density of the kidney protein bands were detected in the electrophoretic examination of the kidney and liver tissue
This uncertainty underscores the importance of adhering to expiration dates and storage requirements established by manufacturers and approved by the FDA
However, significant gaps in research, including inconsistent methodologies, small sample sizes, and limited data on long-term effects, necessitate further robust clinical trials